Patent details

Basic Information

Publication number:

EP2185178

PCT Application Number:

US2008071508

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087968004

PCT Publication Number:

WO2009020802

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY

French Title of Invention:

UTILISATION D'UN COMPOSÉ DU FGF-21 ET D'UN COMPOSÉ DU GLP-1 POUR LE TRAITEMENT DE L'OBÉSITÉ

German Title of Invention:

VERWENDUNG EINER FGF-21-VERBINDUNG UND GLP-1-VERBINDUNG ZUR BEHANDLUNG VON ADIPOSTIAS

SPC Number:

Dates

Filing date:

30/07/2008

Grant date:

23/08/2017

EP Publication Date:

19/05/2010

PCT Publication Date:

12/02/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/08/2017

EP B1 Publication Date:

23/08/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/07/2018

Expiration date:

30/07/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/08/2017

 

 

Name:

ELI LILLY AND COMPANY

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

1

Name:

COSKUN, Tamer

Address:

United States (US)

2

Name:

GLAESNER, Wolfgang

Address:

United States (US)

Priority

Priority Number:

953785 P

Priority Date:

03/08/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/18; A61K 38/26; A61P 3/04;

Publication

European Patent Bulletin

Issue number:

201734

Publication date:

23/08/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/11/2018	Outgoing Correspondence	1